Veterinary Dermatology Market to Reach $30.31 Billion by 2030 Amid Rising Pet Ownership and Skin Disease Prevalence

Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type – Global Forecast to 2030

According to MarketsandMarkets™, the global veterinary dermatology market is projected to grow from USD 20.11 billion in 2025 to USD 30.31 billion by 2030, at a CAGR of 8.5%. This growth reflects increasing awareness of animal skin health, rising pet ownership, and the expanding availability of advanced treatment options.As companion animal care continues to evolve, how are rising dermatological conditions reshaping the veterinary healthcare landscape?

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195447184

Browse

  • 340 Market Data Tables
  • 84 Figures
  • 384 Pages and in-depth TOC on Veterinary Dermatology Market – Global Forecast to 2030”.

 

What is fueling this strong market trajectory?

The increasing incidence of dermatological conditions such as atopic dermatitis, parasitic infestations, fungal infections, and autoimmune skin diseases is significantly driving demand for veterinary dermatology solutions. These conditions affect a wide range of animals, including dogs, cats, cattle, and horses, necessitating both preventive and therapeutic interventions.

How is innovation transforming treatment approaches?

The market is witnessing rapid advancements in biologics, diagnostics, and teledermatology. The introduction of monoclonal antibodies and immunotherapies is improving treatment efficacy, while enhanced diagnostic tools enable early and accurate disease detection. These innovations are not only improving clinical outcomes but also expanding treatment accessibility.

From a treatment standpoint, why is the topical segment leading? Topical therapies—including shampoos, creams, and sprays—accounted for the largest market share in 2024 and are expected to maintain strong growth. Their non-invasive nature, ease of application, and effectiveness in treating infections, allergies, and parasitic conditions make them a preferred choice among veterinarians and pet owners.

Which product segment is emerging fastest?

Antiparasitic drugs are projected to witness the highest CAGR during the forecast period. The increasing prevalence of fleas, ticks, and mites across both companion and livestock animals, coupled with advancements in drug formulations, is driving this segment’s expansion globally.

Why do parasitic infections dominate the condition landscape?

Parasitic infections held the largest market share in 2024 due to their widespread occurrence and significant impact on animal health. Growing awareness and improved diagnostic capabilities are further accelerating demand for effective treatment solutions in this segment.

How is the end-user ecosystem evolving?

Veterinary hospitals and clinics continue to dominate the market, supported by the rising number of veterinary practitioners and expanding healthcare infrastructure. These facilities offer specialized dermatological services, positioning them as key contributors to market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=195447184

Regional Insights:

Which region offers the highest growth potential? The Asia Pacific market is expected to register the fastest growth during the forecast period. Factors such as rising pet adoption, increasing awareness of animal health, and expanding veterinary infrastructure are driving demand in countries like China, India, and Japan. Additionally, the region’s large livestock population and growing demand for animal-derived products further support market expansion.

Market Insights:

Leading players operating in the veterinary dermatology market include Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Zoetis Inc. (US), Boehringer Ingelheim International GmbH (Germany), Virbac (France), Vetoquinol (France), and Dechra Pharmaceuticals plc (UK), among others. These companies are focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.

As veterinary dermatology continues to gain prominence within animal healthcare, stakeholders must align their strategies with emerging trends in biologics, advanced diagnostics, and companion animal care. To explore detailed market insights, competitive benchmarking, and growth opportunities, access the full report today.

Related Reports:

Animal Wound Care Market – Global Forecast to 2030

Veterinary Ultrasound Market– Global Forecast to 2031

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/animal-dermatology-market-195447184.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Veterinary Dermatology Market to Reach $30.31 Billion by 2030 Amid Rising Pet Ownership and Skin Disease Prevalence